Refine by
Ab2 Bio Rheumatic Equipment & Supplies
2 equipment items found
Manufactured by:AB2 Bio Ltd. based inLausanne, SWITZERLAND
The long-term outlook (prognosis) of familial forms without treatment is poor, with a median survival of less than 2 months to 6 months after diagnosis. These disorders can be either inherited (familial or primary) or secondary to other conditions (rheumatic diseases, cancer or infections) such as Macrophage Activation Syndrome (MAS), a severe complication of ...
Manufactured by:AB2 Bio Ltd. based inLausanne, SWITZERLAND
Macrophage Activation Syndrome. Macrophage Activation Sysdrome (MAS) is a very severe complication of rheumatic diseases. Mortality ranges between 10-30% for patients with MAS and there is no registered therapy. MAS occurs frequently in systemic Juvenile Idiopathic Arthritis (soJIA) and in Adult onset Still’s Disease (AOSD) patients. ...
